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Enhancer-associated long noncoding RNAs act over long distances and across chromosomes to
activate transcription at distal promoters. Here, we address the latest advances made toward
understanding the role of long noncoding RNA expression and the involvement of these RNAs in
enhancer function through association with protein factors and modulation of chromatin structure.Introduction
Enhancers are intergenic or intragenic regulatory sequences that
can activate gene expression independent of their proximity or
orientation with respect to their target genes (Bulger and Grou-
dine, 2011). What makes enhancers remarkable is their ability
to control temporal- and tissue-specific gene expression during
development and their possible misregulation, contributing to
a range of human diseases. Enhancer function depends on
interplay between DNA sequences, DNA-binding proteins, and
chromatin architecture, and in the last 3 years, the functional
landscape has gained further complexity with the identification
of enhancer-associated noncoding RNAs. Thus, even though
enhancers were discovered more than 30 years ago, the molec-
ular basis of their function remains elusive.
Simply identifying enhancers used to be a challenge. In recent
years, we have seen a rapid expansion of large-scale prediction
and identification of enhancers based on chromatin marks,
occupancy by critical enhancer-associated factors, and large-
scale transcriptome sequencing (Bulger and Groudine, 2011).
Such genome-wide analyses have uncovered general properties
of enhancers, resulting in the operational definition of enhancers
as distal DNA elements (relative to the transcription start site)
occupied by the transcriptional coactivator p300/CBP and
RNA polymerase II (RNAPII) that often contain permissive
chromatin with nucleosomes bearing histone H3K4 monomethyl
(H3K4me1) and H3K27 acetyl (H3K27ac) modifications (Bulger
and Groudine, 2011). An estimate of enhancer abundance
and nucleotide length suggests that enhancers can make up
as much as 10% of human genomic sequences (Bulger and
Groudine, 2011).
Active Transcription from Enhancers
There are a large number of long noncoding RNAs that fulfill a
range of functions in the nucleus and the cytoplasm (Ulitsky
and Bartel, 2013). Nevertheless, the discovery that enhancers
express long noncoding RNAs came as something of a surprise,
and the observation that these RNAs increase in concentration in
a stimulus-dependent manner suggested that they might confer
an additional layer of regulation in gene expression (De Santa
et al., 2010; Kim et al., 2010).1190 Cell 154, September 12, 2013 ª2013 Elsevier Inc.In several dynamic systems, the transcription of long noncod-
ing RNAs from enhancer regions has been shown to correlate
with the expression of neighboring protein-coding genes. In
mouse neurons, more than 12,000 activity-regulated enhancers
were defined by p300/CBP binding and H3K4Me1, of which
2,000 were shown to bind RNAPII and express bidirectionally
long (2,000 nt) and predominantly nonpolyadenylated noncod-
ing RNAs (Kim et al., 2010). In human macrophages activated
with endotoxin, a similar enhancer prediction approach identi-
fied several enhancers that express nonspliced, polyadenylated
long noncoding RNAs (De Santa et al., 2010). The increase
in concentration of the majority of these transcripts following
treatment of the cells with the endotoxin preceded the induction
of the neighboring protein-coding genes, suggesting a regu-
latory role for long noncoding RNAs in the upregulation of
protein-coding genes in macrophages. A similar pattern of
expression was observed in MCF-7 cells treated with estradiol,
in which the induction of the majority of long noncoding RNAs
also preceded the activation of their target genes (Hah et al.,
2013). Additionally, experiments in T lymphocytes have provided
evidence for binding of RNAPII along with general transcription
factors and transcriptional initiation at several T-lymphocyte-
specific enhancers, resulting in the expression of both polyade-
nylated and nonpolyadenylated long noncoding RNA transcripts
(Koch et al., 2011). Interestingly, some of these long noncoding
RNA-generating T cell enhancers occupied several kilobase-
long transcriptional initiation platforms, reminiscent of recently
described super-enhancers (Whyte et al., 2013). Though these
studies suggested a functional relationship between long non-
coding RNAs generated at enhancer loci and the transcription
of their neighboring genes, they did not establish a requirement
for long noncoding RNAs in transcriptional activation.
Long Noncoding RNAs Display Enhancer-like Function
Two studies subsequently provided evidence for a causal role
in transcriptional activation for enhancer-associated long
noncoding RNAs. These reports used knockdown approaches
to deplete the levels of several long noncoding RNAs in human
cells (Ørom et al., 2010; Wang et al., 2011). Depletion of specific
long noncoding RNAs resulted in repression of neighboring
Figure 1. Long Noncoding RNAs in
Enhancer Looping and Function
Long noncoding RNAs are proposed to func-
tion in the establishment or maintenance of
enhancer promoter looping and activation of
gene expression. In the absence of looping
interactions (upper-left), the enhancer is inac-
tive and transcription is minimal. One model for
activation (counterclockwise) features engage-
ment of enhancer-binding factors, transcrip-
tion factors, and bridging factors such as
the Mediator, Cohesin, and WDR5 complexes
(lower-left), which leads to gene looping
between enhancer and promoter sequences
followed by induction of long noncoding RNA
expression and transcriptional activation of the
target gene (lower-right). A second model pro-
poses that long noncoding RNA transcription
precedes target gene activation and looping
(clockwise), whereby binding of enhancer-
binding factors and transcription of long
noncoding RNAs are the first steps in the activation process (upper-right). Subsequently, a loop to the promoter is established through interactions
with the transcription factors and bridging factors (lower-right), leading to activation of the neighboring gene.protein-coding genes in a cis regulatory manner. Moreover, tran-
scriptional activation could be recapitulated in classical
enhancer assays using heterologous reporters and was shown
to be dependent on long noncoding RNA expression (Ørom
et al., 2010).
Additional evidence for participation of long noncoding RNAs
in transcriptional activation was provided following the analysis
of long noncoding RNAs transcribed from p53-binding sites
using genome-wide approaches to define p53 chromatin
residence (Melo et al., 2013). Depleting RNAs associated with
p53-binding sites resulted in decreased expression of the
neighboring protein-coding genes targeted by p53. Similarly, a
genome-wide study of estrogen receptor-binding sites following
estradiol stimulation identified enhancer sites expressing long
noncoding RNAs, as revealed by global run-on sequencing
(GRO-seq) (Li et al., 2013). Depletion of multiple long noncoding
RNAs in this system resulted in diminished transcription of
the neighboring genes.
Looking at nuclear hormone repression in mouse macro-
phages, Lam et al. proposed that the nuclear receptor Rev-Erb
represses its target genes by binding predominantly to distal
regulatory elements and preventing their ability to transcribe
long noncoding RNAs (Lam et al., 2013). Analysis of specific
candidate genes Mmp9 and Cx3cr1 subject to repression by
Rev-Erb revealed the involvement of neighboring long noncod-
ing RNAs. Importantly, most distal Rev-Erb-binding sites ex-
pressing long noncoding RNAs and overlapping with domains
of H3K4me1were deemed to be specific inmacrophage lineage.
This study points to the requirement for both transcription factor
binding (Rev-Erb) and the presence of specific nucleotide se-
quences of the long noncoding RNA in transcriptional regulation.
Indeed, the regulation of longnoncodingRNAexpressionbyRev-
Erb at distal siteswas amore accuratemeasure of transcriptional
repression of target genes thanwas the occupancy of Rev-Erb at
distal regulatory elements alone. Importantly, the authors
showed the utility of targeting long noncoding RNAs for locus-
and tissue-specific gene regulation in mouse by manipulating
the expression of Mmp9 following depletion of distal Mmp9
long noncoding RNAs rather than targeting theMmp9 gene itself.Enhancer-associated long noncoding RNAs operate in key
physiological processes. For example, experiments analyzing
developmental regulation of neurogenin1, a critical transcription
factor required for brain development, revealed the presence of
distal regulatory elements expressing long noncoding RNAs
(Onoguchi et al., 2012). Functional depletion of these long non-
coding RNAs, termed utNgn1, demonstrated their requirement
for transcriptional activation of neurogenin 1 during development
(Onoguchi et al., 2012). Moreover, through in vivo experiments in
mice, a long noncoding RNA termed NeST was shown to have
enhancer-like functions by activating the neighboring inter-
feron-g locus and conferring microbial susceptibility (Gomez
et al., 2013). Although most studies have focused on the regula-
tion of protein-coding genes through the action of long noncod-
ing RNAs, there are also examples in which long noncoding
RNAs activate a neighboring long noncoding RNA. For instance,
the long noncoding RNA Jpx regulates transcriptional activation
of XIST, the long noncoding RNA that is critical for X inactivation
in mammalian cells (Tian et al., 2010).
Enhancers and Chromosome Conformation
Although the experiments with reporter genes described above
indicated that these long noncoding RNAs can work over short
distances, many enhancers are distant from the promoters that
they regulate, and there must exist augmenting mechanisms
such as chromatin looping and perhaps formation of noncoding
RNA-RNA or noncoding RNA-DNA interactions that allow for
distal long noncoding RNAs to achieve target specificity in vivo.
Indeed, one of the main hypotheses of how enhancers mediate
their function is predicated on the idea that enhancers and
their target promoters associate through a three-dimensional
genomic architecture, bringing about a ‘‘chromatin loop’’ (Bulger
and Groudine, 2011). This regulation has been shown to involve
the interaction of the transcriptional coactivator Mediator and
the chromosome segregationmachinery theCohesin complexes
(Kagey et al., 2010; Phillips-Cremins et al., 2013). In addition,
sequence-specific DNA-binding factors and their designated
transcriptional coactivators play a prominent role in enhancer
function (Figure 1).Cell 154, September 12, 2013 ª2013 Elsevier Inc. 1191
Following the observations that long noncoding RNAs are
required for enhancer activity, recent work has supported the
involvement of long noncoding RNAs in the establishment or
maintenance of chromosome conformation (Lai et al., 2013; Li
et al., 2013). The studies by Lai et el. provided evidence that
the Mediator complex and enhancer-like long noncoding RNAs
are involved in the establishment or maintenance of chromatin
looping between the long noncoding RNA loci and their regu-
lated promoters. Knockdown of either long noncoding RNAs or
Mediator subunits abrogated the chromosomal interactions,
demonstrating an involvement of both the Mediator and the
long noncoding RNA in chromatin looping and enhancer-pro-
moter interactions. It was further shown that such long noncod-
ing RNAs could associate with the Mediator complex and could
stimulate its kinase activity toward phosphorylation of histone 3
serine 10 (H3S10), an important chromatin mark in transcrip-
tional activation (Lai et al., 2013).
A subsequent study assessing the role of long noncoding
RNAs induced by treatment of MCF-7 human breast cancer
cells with 17B-oestradiol (E2) used a different approach and
confirmed the importance of long noncoding RNAs in chromo-
somal conformation (Li et al., 2013). Using a strategy named
three-dimensional DNA selection and ligation (3D-DSL), the
authors identify DNA looping events that are induced between
enhancers and their target promoters. Importantly, depletion of
a number of E2-induced long noncoding RNAs diminished the
looping events concomitant with decreased transcriptional
activation (Li et al., 2013). Importantly, the authors identified
the cohesion complex as a binding partner of E2-induced long
noncoding RNAs and proposed a role for Cohesin in enhancer-
derived chromosome looping. In a related study (Hah et al.,
2013), long noncoding RNA production at estrogen-receptor-
binding sites following estradiol treatment of MCF-7 cells was
strongly correlated with not only the genomic features associ-
ated with enhancers (H3K4me1, H3K27ac, p300, RNAPII, and
open chromatin architecture), but also with the DNA looping be-
tween enhancers and their target promoters. However, inhibition
of long noncoding RNA production using the transcriptional
elongation inhibitor flavopiridol did not affect the chromatin loop-
ing between enhancers and their target promoters. Though it is
difficult to have a clear interpretation of these results, as flavopir-
idol also inhibits the expression of protein-coding genes, it may
suggest that the prior synthesis of long noncoding RNAs may be
sufficient to maintain chromatin looping. These results may,
therefore, delineate a role for long noncoding RNAs in the main-
tenance of the DNA looping rather than its establishment.
It is also likely that not all genomic loci require long noncoding
RNAs for DNA looping between enhancers and promoters.
Indeed, although a role for the long noncoding RNA HOTTIP in
chromatin looping across the human HOXA locus was sug-
gested, depletion of HOTTIP did not affect the overall chromatin
architecture, as measured by high-throughput chromosome
conformation capture (Wang et al., 2011). A similar scenario
was reported in studies analyzing p53-mediated transcriptional
activation (Melo et al., 2013), wherein chromatin looping be-
tween p53-binding sites and their targets was deemed to be
p53 independent, whereas long noncoding RNA expression at
p53-binding sites was p53 dependent. The authors proposed1192 Cell 154, September 12, 2013 ª2013 Elsevier Inc.that chromatin looping is established prior to p53-mediated acti-
vation and therefore prior to synthesis of long noncoding RNAs
at p53 sites. Given these distinct results, further experiments
are required to understand the precise contribution of long non-
coding RNAs to chromatin architecture at specific genomic loci.
More Than One Kind of Activating RNA
The repertoire of long noncoding RNAs displaying enhancer-like
activity is wider than originally thought. The initial identification of
long noncoding RNAs with activating function focused on a
class of long noncoding RNAs with gene loci that do not overlap
with protein-coding genes. These long noncoding RNAs are
expressed from independent transcription units and are pre-
dominantly spliced and polyadenylated (Gomez et al., 2013;
Onoguchi et al., 2012; Ørom et al., 2010; Wang et al., 2011).
Based on their genomic localization, these long noncoding
RNAs were named intergenic or intervening long noncoding
RNAs (lincRNAs). LincRNAs with activating function were
operationally called ncRNA-activating (ncRNA-a). Many of these
ncRNA-a are developmentally regulated and are responsive to
differentiating stimuli (Onoguchi et al., 2012; Ørom et al., 2010;
Wang et al., 2011).
On the other hand, long noncoding RNAs expressed from
distal regulatory elements, though responsive to stimulus-
dependent activation, comprise a class of bi- and unidirectional
RNAs that contain a mixture of nonpolyadenylated and polyade-
nylated species (De Santa et al., 2010; Kim et al., 2010). These
stimulus-induced long noncoding RNAs are termed enhancer
RNAs (eRNAs) and constitute a heterogeneous class of long
noncoding RNAs that is still not well annotated. Although the
precise overlap between ncRNA-a and eRNAs is not clear,
growing evidence suggests that, despite perceived differences
in the biogenesis of these long noncoding RNA classes, they
exert their functional effects on neighboring protein-coding
genes through a common molecular underpinning by promot-
ing chromatin looping to allow enhancer-promoter interactions
(Lai et al., 2013; Li et al., 2013).
Do Long Noncoding RNAs Exert Their Function through
a cis- or trans-Mediated Mechanism?
An important mechanistic question underlying long noncoding
RNA function is whether they achieve transcriptional activation
through a cis- or trans-mediated mechanism. A number of char-
acteristics of activating long noncoding RNAs favor their function
through a cis-mediated manner (that is, acting in proximity to the
region from which they are transcribed). These characteristics
include their low levels of expression, their predominant effect
on neighboring genes, and their nuclear localization, as they
are often closely associated with chromatin. However, there
are examples in which long noncoding RNAs may activate their
targets in trans. Jpx, an activating long noncoding RNA, was
proposed to mediate its effects on the XIST RNA in trans (Tian
et al., 2010) by evicting CTCF from the XIST promoter (Sun
et al., 2013). One of the strongest examples of an activating
long noncoding RNA functioning in trans isNeST, a long noncod-
ing RNA that activates the IFN-g locus contributing to microbial
susceptibility (Gomez et al., 2013). The functional consequences
of loss ofNeST inmice could be rescued through overexpression
of the long noncoding RNA in transgenic animals, underscoring
the importance of the long noncoding RNA in this immune
context.
Long noncoding RNAs with activating function may also re-
cruit transcriptional activators or critical chromatin regulatory
complexes to enhancers or their corresponding targets. Such
physical recruitment of regulatory complexes could be achieved
either in cis via locally produced activating RNAs or in trans,
where activating RNAs direct the recruitment of a specific
complexes to a target loci in vivo. Taken together, the previous
designation of enhancers as distal DNA regulatory elements
allowed only for cis-mediated regulation of their target genes
through transcription factor binding and chromatin looping.
However, the emergence of long noncoding RNAs as dynamic
molecular mediators of transcriptional activation provides for
novel mechanisms of gene activation by which the long non-
coding RNAs, through recruitment of coactivator complexes
and regulatory factors, could mediate transcriptional activation
in trans (Figure 1).
Outlook
The discovery of long noncoding RNAs with activating function
and their intimate association with distal regulatory elements
(enhancers) has profound implications for our understanding of
gene regulation during differentiation, development, and disease
progression. We have spent the last 20 years analyzing gene
expression programs in healthy tissues and in disease states
by profiling expression changes in protein-coding genes. The
realization that tissue- and temporal-specific regulation of gene
expression is governed by long noncoding RNAs expressed at
enhancers provides us with an opportunity to analyze additional
key regulatory molecules that may provide a greater insight into
locus-specific gene regulation during disease development and
progression. Moreover, although recent experiments have shed
some light on the mechanisms by which this class of long
noncoding RNAs functions, we are still in the early stages of fully
understanding the long noncoding RNA code(s) required for
activating function. It will be highly informative to understand
the long noncoding RNA sequence determinants or structural
requirements (secondary or tertiary) that govern enhancer
function. It is also of prime importance to determine the allele
specificity of the RNAs’ activating function. Though multiple
studies have pointed to cis-mediated function of some activating
RNAs, whether activation is restricted to a single allele or can
extend to both alleles has not been addressed and is a critical
question that may reveal a broad and critical function for acti-
vating long noncoding RNAs in dosage compensation.
Given that RNA is an evolutionary predecessor of proteins,
long noncoding RNA-mediated regulation of transcription may
represent an ancient mechanism by which gene expression
was regulated long before the appearance of proteins. As we
continue to accumulate insights into these regulatory RNAs, itonly becomes more apparent that there are new and unantici-
pated layers of regulation for tissue- and temporal-specific
gene expression waiting to be discovered.
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